Gene · 56606
Papers1,527
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,527
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Innovative modeling: a diet-induced quail model for progressive pathological changes in uric acid metabolism disorders. | Front Nutr | 2025 | 40771212 | PubTator, text mining | PubMed |
| Local genetic sex differences in quantitative traits. | Nat Commun | 2025 | 40770183 | PubTator, text mining | PubMed |
| Limosilactobacillus fermentum M5e Attenuates Hyperuricemia and Renal Injury via Dual Modulation of Gut Microbiota and Purine Metabolic Pathways. | ACS Pharmacol Transl Sci | 2025 | 40757060 | PubTator, text mining | PubMed |
| Sex-specific DNA methylation associations with circulating urate levels and BCG-induced urate changes. | Commun Med (Lond) | 2025 | 40745483 | PubTator, text mining | PubMed |
| Comparison between compositional data analysis and principal component analysis for identifying dietary patterns associated with hyperuricemia. | Front Nutr | 2025 | 40740650 | PubTator, text mining | PubMed |
| Effects of tris(2-chloroethyl)phosphate on hyperuricemia revealed by network toxicology and in vitro experimental validation. | Drug Chem Toxicol | 2025 | 40643037 | PubTator, text mining | PubMed |
| Association of SNPs in carbohydrate metabolism genes with insulin resistance indicators in the Mexican population. | Nutr Metab (Lond) | 2025 | 40598536 | PubTator, text mining | PubMed |
| Structural Insights into the Substrate Egress Pathways Explains Specificity and Inhibition of Human Glucose Transporters (GLUT1 and GLUT9). | ACS Pharmacol Transl Sci | 2025 | 40534680 | PubTator, text mining | PubMed |
| The effects of GLUT9 and URAT1 inhibitors on cardiovascular diseases: a drug-targeted Mendelian randomization study. | Int Urol Nephrol | 2025 | 40478372 | PubTator, text mining | PubMed |
| Acute Kidney Injury and Chronic Kidney Disease Associated with a Genetic Defect: A Report of Two Cases. | Int J Mol Sci | 2025 | 40429823 | PubTator, text mining | PubMed |
| Single Nucleotide Variants of the SLC2A9 Gene Are Associated with Hyperuricemia in Mexican Patients with Type 2 Diabetes. | Arch Med Res | 2025 | 40373704 | PubTator, text mining | PubMed |
| Effects of dietary protein sources and levels on uric acid metabolism, renal function, and inflammatory responses in goslings. | Front Vet Sci | 2025 | 40365127 | PubTator, text mining | PubMed |
| Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect. | Eur J Med Chem | 2025 | 40305938 | PubTator, text mining | PubMed |
| Editorial: Case reports in nephrology. | Front Nephrol | 2025 | 40260144 | PubTator, text mining | PubMed |
| Mechanistic insights into the potentiation and toxicity mitigation of myocardial infarction treatment with salvianolate and ticagrelor. | Phytomedicine | 2025 | 40209643 | PubTator, text mining | PubMed |
| Structural basis of urate transport by glucose transporter 9. | Cell Rep | 2025 | 40186864 | PubTator, text mining | PubMed |
| Analysis of microRNA expression in patients with uric acid calculi. | Urolithiasis | 2025 | 40186757 | PubTator, text mining | PubMed |
| Adipocyte-secreted ANGPTL2 promotes hyperuricemia through inhibiting AKT/ABCG2 signaling. | Free Radic Biol Med | 2025 | 40180020 | PubTator, text mining | PubMed |
| Oleanolic Acid Alleviates Hyperuricemia via Gut Microbiota Control the Integrity of Gut Barrier and the Expressions of Urate Transporter in Mice. | J Agric Food Chem | 2025 | 39973149 | PubTator, text mining | PubMed |
| Evaluation of anti-hyperuricemic and nephroprotective activities and discovery of new XOD inhibitors of Morus alba L. root bark. | J Ethnopharmacol | 2025 | 39938762 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56606/papers?page=4